Guru Ownership Trend
Guru Analysis for Dianthus Therapeutics, Inc. (DNTH)
Dianthus Therapeutics, Inc. (DNTH), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $74.61 M.
Top institutional holders include Steven Cohen and Jefferies Group.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $27.95 M net outflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position. Conversely, Steven Cohen reduced exposure by 44.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Dianthus Therapeutics, Inc. (DNTH)
Major holders include Steven Cohen ($54.01 M), Jefferies Group ($16.99 M), Ken Fisher ($1.06 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 862,747 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $27.95 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited DNTH. The total reported sell value was $45.28 M.
Yes, 2 managers opened new positions in DNTH, and 0 increased their existing holdings. The total reported buy value was $17.33 M.